{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:MAP1LC3",
      "entity_text" : "LC3",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF00183",
      "entity_text" : "Hsp90",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "In contrast, inhibition of Hsp90 expression in A549 and H460 cells by siRNA against Hsp90 or treatment with 17-AAG (an Hsp90 inhibitor) significantly increased LC3 puncta accumulation and LC3-II conversion in HyFS treated cells.",
  "reading_complete" : "2020-08-02T10:14:25Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T10:12:42Z",
  "trigger" : "increased",
  "evidence" : [ "Hsp90 expression in A549 and H460 cells by siRNA against Hsp90 or treatment with 17-AAG (an Hsp90 inhibitor) significantly increased LC3" ],
  "pmc_id" : "5858516",
  "score" : 0
}